The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1B dose escalation study of ETC-159 in combination with pembrolizumab in advanced or metastatic solid tumours.
 
David Shao Peng Tan
Stock and Other Ownership Interests - Asian Microbiome Library
Honoraria - AstraZeneca; Bayer; Eisai; Foundation Medicine; Merck; MSD; Roche; Turbine
Consulting or Advisory Role - AstraZeneca; Bayer; Eisai; GlaxoSmithKline; Merck; MSD; Roche
Speakers' Bureau - Roche
Research Funding - AstraZeneca; Bayer; Karyopharm Therapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Merck; Novartis; Roche
 
Matthew C.H. Ng
Honoraria - ASLAN Pharmaceuticals; AstraZeneca; BMS Singapore; Bristol-Myers Squibb Singapore; Bristol-Myers Squibb/Ono Pharmaceutical; DKSH; Lilly; MSD Oncology; MSD Oncology; Novartis; Taiho Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - AstraZeneca; AstraZeneca; BMS Singapore; Bristol-Myers Squibb; Bristol-Myers Squibb; DKSH; Merck; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; MSD Oncology; Novartis
Speakers' Bureau - MSD Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Taiho Pharmaceutical
 
Vivek Subbiah
Consulting or Advisory Role - Helsinn Therapeutics; Loxo/Lilly; MedImmune; Pfizer; Relay Therapeutics
Research Funding - Abbvie (Inst); Agensys (Inst); Alfasigma (Inst); Amgen (Inst); Amgen (Inst); Bayer (Inst); Berg Pharma (Inst); Blueprint Medicines (Inst); Boston Biomedical (Inst); D3 Oncology Solutions (Inst); Exelixis (Inst); Fujifilm (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Idera (Inst); Incyte (Inst); Inhibrx (Inst); LOXO (Inst); Multivir (Inst); NanoCarrier (Inst); Northwest Biotherapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Relay Therapeutics (Inst); Takeda (Inst); Turning Point Therapeutics (Inst); Vegenics (Inst)
Travel, Accommodations, Expenses - Bayer; Foundation Medicine; Helsinn Therapeutics; Novartis; PharmaMar
Other Relationship - Medscape
 
Wells A. Messersmith
Honoraria - Research to Practice (Inst)
Consulting or Advisory Role - Amgen; Criterium (Inst); QED Therapeutics; Zymeworks
Research Funding - ALX Oncology (Inst); Beigene (Inst); CanBas (Inst); D3 (Inst); Exelixis (Inst); FATE Therapeutics (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); PureTech (Inst); RasCal (Inst)
 
John H Strickler
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Beigene; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Inivata; Lilly; Natera (Inst); Pfizer; Pionyr; Roche/Genentech; Seagen; Silverback Therapeutics; Takeda; Viatris; Zentalis
Research Funding - A*STAR (Inst); Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene; Curegenix (Inst); Daiichi Sankyo/Lilly; Erasca, Inc (Inst); Leap Therapeutics (Inst); Lilly (Inst); Nektar (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Silverback Therapeutics (Inst)
Travel, Accommodations, Expenses - Seagen
 
veronica diermayr
Employment - A*STAR; Experimental Drug Development Centre (EDDC)/A*STAR
Patents, Royalties, Other Intellectual Property - Patent: diagnostic test for ETC-159; Patent: ETC-159 combination therapy with pembrolizumab
 
Julienne Cometa
No Relationships to Disclose
 
Stephanie Blanchard
No Relationships to Disclose
 
Ranjani Nellore
No Relationships to Disclose
 
Vishal Pendharkar
No Relationships to Disclose
 
Bong Hwa Gan
No Relationships to Disclose
 
Nurul Nazihah Rozaini
No Relationships to Disclose
 
Claudia Koh
No Relationships to Disclose
 
Suman Sarma
No Relationships to Disclose
 
Huay Mei Poh
No Relationships to Disclose
 
Alexander Lezhava
No Relationships to Disclose
 
VENKATESHAN SRIRANGAM PRATIVADIBHAYANKARAM
Stock and Other Ownership Interests - Abbott Laboratories